A Study to Evaluate the Effect of Single-Dose Intravenous Rifampin as a Prototypic Inhibitor of Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 on the Single-Dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants
Clinical trial NCT04121078 · COMPLETED
Trial details
- NCT number
- NCT04121078
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-15
- Primary completion
- 2019-11-04
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.